A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
Public ClinicalTrials.gov record NCT03100058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a dose-finding study that evaluated the change in weight after 24 weeks treatment with 8 different doses of LIK066 compared to placebo in obese or overweight adults, followed by 24 weeks treatment with 2 doses of LIK066 and placebo.
Study identification
- NCT ID
- NCT03100058
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 460 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2017 (Actual)
- Primary completion
- Mar 2, 2018 (Actual)
- Completion
- Aug 2, 2018 (Actual)
- Last update posted
- Feb 6, 2020
2017 – 2018
United States locations
- U.S. sites
- 59
- U.S. states
- 24
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Anniston | Alabama | 36207 | — |
| Novartis Investigative Site | Jasper | Alabama | 35501 | — |
| Novartis Investigative Site | Beverly Hills | California | 90211 | — |
| Novartis Investigative Site | Carmichael | California | 95608 | — |
| Novartis Investigative Site | Concord | California | 94520 | — |
| Novartis Investigative Site | Los Angeles | California | 90017 | — |
| Novartis Investigative Site | Northridge | California | 91325 | — |
| Novartis Investigative Site | Roseville | California | 95661 | — |
| Novartis Investigative Site | San Ramon | California | 94582 | — |
| Novartis Investigative Site | Stockton | California | 95204 | — |
| Novartis Investigative Site | Walnut Creek | California | 94598 | — |
| Novartis Investigative Site | Denver | Colorado | 80246 | — |
| Novartis Investigative Site | Golden | Colorado | 80401 | — |
| Novartis Investigative Site | Bradenton | Florida | 34209 | — |
| Novartis Investigative Site | Fort Lauderdale | Florida | 33312 | — |
| Novartis Investigative Site | Port Charlotte | Florida | 33952 | — |
| Novartis Investigative Site | West Palm Beach | Florida | 33401 | — |
| Novartis Investigative Site | Athens | Georgia | 30606 | — |
| Novartis Investigative Site | Augusta | Georgia | 30909 | — |
| Novartis Investigative Site | Honolulu | Hawaii | 96814 | — |
| Novartis Investigative Site | Gurnee | Illinois | 60031 | — |
| Novartis Investigative Site | Springfield | Illinois | 62711 | — |
| Novartis Investigative Site | Wauconda | Illinois | 60084 | — |
| Novartis Investigative Site | Evansville | Indiana | 47713 | — |
| Novartis Investigative Site | Evansville | Indiana | 47714 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46260 | — |
| Novartis Investigative Site | Louisville | Kentucky | 40213 | — |
| Novartis Investigative Site | Baton Rouge | Louisiana | 70808 | — |
| Novartis Investigative Site | Covington | Louisiana | 70433 | — |
| Novartis Investigative Site | Hammond | Louisiana | 70403 | — |
| Novartis Investigative Site | Metairie | Louisiana | 70006 | — |
| Novartis Investigative Site | New Orleans | Louisiana | 70115 | — |
| Novartis Investigative Site | New Orleans | Louisiana | 70119 | — |
| Novartis Investigative Site | Baltimore | Maryland | 21229 | — |
| Novartis Investigative Site | Beltsville | Maryland | 20705 | — |
| Novartis Investigative Site | Towson | Maryland | 21204 | — |
| Novartis Investigative Site | Royal Oak | Michigan | 48073 | — |
| Novartis Investigative Site | City of Saint Peters | Missouri | 63303 | — |
| Novartis Investigative Site | St Louis | Missouri | 63128 | — |
| Novartis Investigative Site | Missoula | Montana | 59808 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | New York | New York | 10016 | — |
| Novartis Investigative Site | New York | New York | 10021 | — |
| Novartis Investigative Site | The Bronx | New York | 10455 | — |
| Novartis Investigative Site | Hickory | North Carolina | 28601 | — |
| Novartis Investigative Site | Lansdale | Pennsylvania | 19446 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15212 | — |
| Novartis Investigative Site | Moncks Corner | South Carolina | 29464 | — |
| Novartis Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Novartis Investigative Site | Summerville | South Carolina | 29485 | — |
| Novartis Investigative Site | Houston | Texas | 77081 | — |
| Novartis Investigative Site | Bountiful | Utah | 84010 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84102 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Richmond | Virginia | 23235 | — |
| Novartis Investigative Site | Richmond | Virginia | 23294 | — |
| Novartis Investigative Site | Renton | Washington | 98057 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
| Novartis Investigative Site | Kenosha | Wisconsin | 53144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03100058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03100058 live on ClinicalTrials.gov.